Tumor-suppressive roles of PHLDA3 protein have been reported in several cancer cell lines including ESCC, osteosarcoma (OS), acute myeloid leukemia (AML), B-cell lymphoma, and prostate cancer [6,13,42]. This evidence concerns the gene PHLDA3 and B-cell non-Hodgkin lymphoma.